Skip to content
Screener

AngioDynamics ANGO Med Tech — Net Sales

Other product segments

Med Device
$44.85M

Similar metrics at other companies

Stryker logo
SYKOrtho Tech — Net Sales
$646M+4.7%
Smurfit Kappa Group logo
SWEurope, MEA and APAC — Net Sales
$2.82B+1.4%
General Mills logo
GISPet — Net Sales
$746.6M+5.8%
Smurfit Kappa Group logo
SWOther Europe, MEA and APAC — Net Sales
$1.79B+15.6%
Spectrum Brands Holdings logo
SPBEurope/MEA — Net Sales
$201.1M+2.1%
Wabash National logo
WNCNew trailers — Net Sales
$317.05M+1.6%

Other financials

Income statement

See full
Revenue$86.6M+8.0%
Gross profit$46.8M+10.8%
Operating income-$10.2M-76.1%
Net income-$11.4M-88.5%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$53.9M-3.6%
Total debt$11.0M+8.0%
Total equity$170.8M-6.6%
Total assets$267.2M-4.6%

Cash flow

See full
Operating cash flow$17.5M
CapEx$413.0K-46.8%
Free cash flow$17.0M

Valuation

See full
Market cap$648.51M+88.9%
Enterprise value$605.6M+103%
P/S+0.9×

Profitability

See full
Gross margin54.6%+0.7pp
Operating margin-12.5%-1.0pp
Net margin-11.5%-0.1pp
FCF margin0.2%

Returns & leverage

See full
Return on equity-20.8%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: AngioDynamics’s 10-K, filed July 14, 2026.

Filed
Jul 14, 2026, 3:42 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-048138
(in thousands)Year ended May 31, 2026 / United StatesYear ended May 31, 2026 / InternationalYear ended May 31, 2026 / TotalYear ended May 31, 2025 / United StatesYear ended May 31, 2025 / InternationalYear ended May 31, 2025 / Total
Net sales
Med Tech$129,830$20,124$149,954$109,254$17,399$126,653
Med Device145,09325,127170,220141,72924,116165,845
Total$274,923$45,251$320,174$250,983$41,515$292,498

Item 15. Exhibits, Financial Statement Schedules.

FAQ

What is AngioDynamics's med tech — net sales?
AngioDynamics (ANGO) reported med tech — net sales of $41.76M in Q1 2026.
How has AngioDynamics's med tech — net sales changed year-over-year?
AngioDynamics's med tech — net sales increased by 16.7% year-over-year, from $35.79M to $41.76M.
What is the long-term trend for AngioDynamics's med tech — net sales?
Over 4 years (2022 to 2026), AngioDynamics's med tech — net sales has grown at a 17.5% compound annual growth rate (CAGR), from $78.72M to $149.95M.
What does med tech — net sales mean?
Net sales for the Med Tech segment reflect the total revenue generated from the sale of medical, surgical, and diagnostic devices after accounting for returns, allowances, and discounts. This metric is the primary measure of the segment's market demand and top-line growth trajectory. It provides insight into the company's ability to capture market share within its specialized healthcare product categories.

Ask your AI about AngioDynamics's med tech — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude